REV Group said that Maureen O’Connell has been appointed as an independent member of its board of directors, effective Aug. 25. She succeeds Justin Fish, who has resigned after seven years serving as a board director. O’Connell will also sit on the Nomination and Governance Committees.
“On behalf of the Board of Directors, I want to thank Justin for his valuable contributions to REV Group over the past seven years,” said Paul Bamatter, Chairman of REV Group’s board of directors. “We are delighted to announce Maureen’s election to the board. She is a seasoned business leader with experience in finance, operations, and board oversight of companies across multiple industries. Maureen’s diversity of experience will help broaden the skills of the current board and be invaluable to REV Group as it continues to execute on its vision.”
In addition to REV Group, O’Connell currently is a board member and audit chair for Northwest Healthcare Properties REIT, a board member and audit chair for HH Global, and a board member for Arix Bioscience. O’Connell is also a board member and audit chair for Acacia Research, serving as audit chair since 2019, chairman from May 2019 until November 2022, and lead director since July 2023.
O’Connell’s career spans 30 years of progressive experience in finance and operations management at several global public companies.
